Sign in
4/A

Changes in Ownership

IMMUCELL CORP /DE/ Filed Acc 0001437749-26-009312

Options or other derivatives

  • President and CEO acquired 109,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

te Boekhorst Paul Francis Olivier · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-27 Grant or award : show line 1 in the form Stock Options (right to buy) +109,500 109,500 D
Loading xslF345X06/rdgdoc.xml…